Tag: biopharmaceutical
PAOG Targets International Segment Of $5 Billion CBD Nutraceutical Market
Sandusky, OH, May 13, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion
PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday
Sandusky, OH, May 5, 2021 – OTC PR WIRE — PAO Group, Inc. (USOTC: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived
PAOG CBD Nutraceuticals To Hit Market This Year
Sandusky, OH, May 4, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive
PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday
Sandusky, OH, May 3, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive
PAOG Anticipates Boost To CBD Pharmaceutical Research Initiative From Improving Cannabis Legalization Outlook
Sandusky, OH, April 28, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent cannabis legalization progress anticipated to enhance PAOG’s ongoing CBD Pharmaceutical Development Program. PAOG has partnered with Puration, Inc. (OTC Pink: PURA) to build a pharmaceutical grade indoor hemp grow facility and CBD extraction facility in
Link Reservations Inc./LinkResPet (LRSV) Developing CBD Product To Combat Pet Obesity
London, UK, April 21, 2021 – OTC PR WIRE — Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces it is exploring the development of a new LinkResPet CBD product to aid pets dealing with obesity and weight problems. The
Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon
Nutra Pharma is announcing their newest product, Luxury Feet; is now available for purchase on Amazon.com Plantation, Florida, April 15, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing
Link Reservations Inc./LinkResPet (LRSV) Launches Functional Mushroom Product
London, UK, April 14, 2021 – OTC PR WIRE — Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces the launch of DailyLife CBD Immune, its immune boosting functional mushroom product. Featuring a combination of CBD and a spectrum of functional mushrooms
PAOG Announces Opportunity To Expand CBD Pharmaceutical Research
Sandusky, OH, April 13, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived
PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021
Sandusky, OH, April 12, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is
Recent Posts
Archives
Categories
- Aerospace
- Agriculture
- Aircraft
- Alternative Energy
- ALYI
- Apparel
- Applications
- Arts
- AUTOMOTIVE
- Autoparts
- Banking
- Barchart
- Basketball
- Beauty Products
- Benzinga
- Beverage
- Biotechnology
- Bitcoin
- Blockchain
- Branding
- Building Material
- CANNABIS
- CBD
- Cloud
- Coffee
- Communication
- Construction
- Consumer
- Corporate
- COVID_19
- COVID-19
- Crew Management
- CRM
- Cryptocurrency
- CSE
- Digital
- Digital Currency
- ECommerce
- EDM MEDIA
- EIN Newswire
- Electric Vehicles
- Energy
- Entertainment
- Environment
- Events
- Export
- Fashion
- Featured
- Film
- Financial
- Fintech
- Fitness
- Fleet Management
- Food
- Food for thought
- Frozen Food
- Ftiness
- Fuel
- GALENFEHA
- Gaming
- GEGR
- Gold
- Government
- GPS Tracking
- Healthcare
- HEMP
- ICO
- IMTL
- INSIDER FINANCIAL
- Insurance
- Internet
- Investingcom
- Investment
- Investor Relations
- IoT
- Jewelry
- Lifestyle
- Logistic
- Manufacturing
- Marijuana
- Marketing
- Media
- Medical
- Merger & Acquisition
- Mining
- Moodys
- Motorcycle
- NASDAQ
- Network
- Newsroom
- NFT
- Nutrition
- NYSE
- Oil & Gas
- Online
- OTC Markets
- OTCQB
- OTT
- PAOG
- Pet
- Pharmaceutical
- Precious Metals
- Psychedelic Mushroom
- Public Relations
- Publicity
- QMedia
- Quote
- Rare Earth
- Real Estate
- Renewable Energy
- Renovable Energy
- Rental
- Retail
- RF Components
- RLTR
- SaaS
- Science
- Security
- SFIN
- Shareholders
- Shipping
- Skincare
- Social Media
- Software
- Solar Energy
- Spirits
- Sports
- SSET
- Staffing
- Streaming
- Supplements
- Tech
- Telecommunication
- Television
- Tequila
- Transportation
- UCIX
- Uncategorized
- Video Post
- VR
- Waste Treatment
- Water Treatment
- Wellness
- Wind Power
Contact Us
- 707-OTC-WIRE (707-682-9473)
- cs@otcprwire.com
Recent Comments